Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lokelma (sodium zirconium cyclosilicate) for the Treatment of Adults with Hyperkalaemia

Drug Name

Lokelma (sodium zirconium cyclosilicate)

Developer

AstraZeneca

Therapy Class

Renin-angiotensin-aldosterone system (RAAS) inhibitor therapy

Current Indication

Hyperkalaemia

Market Sector

Cardiovascular

Development Status

Approved in the US and Europe
Expand

Go Top